MarketBrief


133 stories

Source Document

All Filings 130 Press 3

SEC Filing Type

All
8-K 36
Events or Changes Between Quarterly Reports
4 14
Insider Trading
3 7
Insider Trading (Form 3)
S-1/A 7
IPO Registration (Amendment)
10-Q 6
Quarterly Reports
REGDEX/A 6
REGDEX Filing (Amendment)
UPLOAD 6
UPLOAD Filing
3/A 4
Insider Trading (Form 3) Amendment
424B5 4
Prospectus
SC 13G 4
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10-K 3
Annual Reports
EFFECT 3
Filing EFFECT
4/A 2
Insider Trading (Form 4) Amendment
CORRESP 2
Correspondence
D 2
Form D
DEF 14A 2
Definitive proxy statements
REGDEX 2
REGDEX Filing
S-1MEF 2
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S 1
SC 13G/A 2
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions (Amendment)

  1. Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Ventrus Bioscences, Inc. (NASDAQ: VTUS)

    Marketwire 5-12-2013

    OKLAHOMA CITY, OK--(Marketwired - May 12, 2013) - On May 9, 2013, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Ventrus Bioscen...

  2. Ventrus Biosciences Inc files Form 10-Q (Quarterly Reports) SEC Filing

    SEC Filing 5-10-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed Form 10-Q (Quarterly Reports) today.

  3. VENTRUS BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ventrus Biosciences, Inc. - VTUS

    Marketwire 5-10-2013

    NEW ORLEANS, LA--(Marketwired - May 9, 2013) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until...

  4. Ventrus Biosciences Inc files Form DEFA14A (DEFA14A Filing) SEC Filing

    SEC Filing 4-19-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed Form DEFA14A (DEFA14A Filing) today.

  5. Ventrus Biosciences Inc files Form DEF 14A (Definitive proxy statements) SEC Filing

    SEC Filing 4-19-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed Form DEF 14A (Definitive proxy statements) today.

  6. Ellison Russell H receives a grant or award involving derivative securities of Ventrus Biosciences Inc (VTUS) stock

    SEC Filing 4-09-2013

  7. Barrett David Jonathan receives a grant or award involving derivative securities of Ventrus Biosciences Inc (VTUS) stock

    SEC Filing 4-09-2013

  8. Ventrus Biosciences Inc Files 8-K : Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, ...

    SEC Filing 4-09-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed an 8-K statement with the U.S. Securities Exchange Commission today.

  9. Zeldes & Haeggquist, LLP Announces Investigation of Ventrus Biosciences, Inc.

    Business Wire 4-08-2013

    SAN DIEGO--(BUSINESS WIRE)--Zeldes & Haeggquist is investigating a securities class action against Ventrus Biosciences, Inc. (NASDAQ: VTUS) concerning statements made to shareholders regarding its dr...

  10. Altig Anthony E receives a grant or award involving Ventrus Biosciences Inc (VTUS) stock

    SEC Filing 3-22-2013

    Altig Anthony E received a grant or award for 15,000 shares of Ventrus Biosciences Inc (VTUS) stock as noted in an SEC Filing today.

  11. Ventrus Biosciences Inc files Form 10-K (Annual Reports) SEC Filing

    SEC Filing 3-18-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed Form 10-K (Annual Reports) today.

  12. Ventrus Biosciences Inc Files 8-K

    SEC Filing 2-07-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed an 8-K statement with the U.S. Securities Exchange Commission today.

  13. Ventrus Biosciences Inc (VTUS): $38,194 of stock bought by Ellison Russell H

    SEC Filing 2-06-2013

    Ellison Russell H purchased 15,000 shares of Ventrus Biosciences Inc stock, or $38,194 worth, as noted in an SEC Filing today. As reported in the filing, the transactions occurred between February 4, 2013 - February 5, 2013. After the transaction, Ellison Russell H's stake was reported as 15,000 shares of Ventrus Biosciences Inc stock.

  14. Ventrus Biosciences Inc Files 8-K

    SEC Filing 2-04-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed an 8-K statement with the U.S. Securities Exchange Commission today.

  15. Ventrus Biosciences Inc files Form 424B5 (Prospectus) SEC Filing

    SEC Filing 1-31-2013

    Ventrus Biosciences Inc, based in NEW YORK, NY, filed Form 424B5 (Prospectus) today.

 
View More >


Corporate Filings
Other Documents
About